AU1631700A - Tumor antigen-specific antibody-gp39 chimeric protein constructs - Google Patents

Tumor antigen-specific antibody-gp39 chimeric protein constructs

Info

Publication number
AU1631700A
AU1631700A AU16317/00A AU1631700A AU1631700A AU 1631700 A AU1631700 A AU 1631700A AU 16317/00 A AU16317/00 A AU 16317/00A AU 1631700 A AU1631700 A AU 1631700A AU 1631700 A AU1631700 A AU 1631700A
Authority
AU
Australia
Prior art keywords
specific antibody
tumor antigen
chimeric protein
protein constructs
constructs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16317/00A
Inventor
Marco A. Coccia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Idec Pharmaceuticals Corp
Original Assignee
Idec Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idec Pharmaceuticals Corp filed Critical Idec Pharmaceuticals Corp
Publication of AU1631700A publication Critical patent/AU1631700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU16317/00A 1998-11-23 1999-11-23 Tumor antigen-specific antibody-gp39 chimeric protein constructs Abandoned AU1631700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10960798P 1998-11-23 1998-11-23
US60109607 1998-11-23
PCT/US1999/027654 WO2000030680A1 (en) 1998-11-23 1999-11-23 Tumor antigen-specific antibody-gp39 chimeric protein constructs

Publications (1)

Publication Number Publication Date
AU1631700A true AU1631700A (en) 2000-06-13

Family

ID=22328583

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16317/00A Abandoned AU1631700A (en) 1998-11-23 1999-11-23 Tumor antigen-specific antibody-gp39 chimeric protein constructs

Country Status (2)

Country Link
AU (1) AU1631700A (en)
WO (1) WO2000030680A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2099826E (en) 2007-01-05 2014-01-09 Univ Zuerich Anti-beta-amyloid antibody and uses thereof
ES2637214T3 (en) 2007-03-13 2017-10-11 Universität Zürich Specific human monoclonal antibody for each tumor
EP2527369A3 (en) 2007-09-13 2012-12-19 University Of Zurich Prorektorat Forschung Monoclonal amyloid beta (abeta)-specific antibody and uses thereof
MX2011006422A (en) 2008-12-19 2011-09-15 Panima Pharmaceuticals Ag Human anti-alpha-synuclein autoantibodies.
US8940272B2 (en) 2010-10-11 2015-01-27 University Of Zurich Human anti-tau antibodies
EP2651979B1 (en) 2010-12-17 2019-08-28 Neurimmune Holding AG Human anti-sod1 antibodies
EA030777B9 (en) 2011-06-23 2019-02-28 Байоджен Интернэшнл Нейросайенз Гмбх Anti-alpha synuclein binding molecules
DE202011103324U1 (en) 2011-07-12 2012-01-02 Nekonal S.A.R.L. Therapeutic anti-TIRC7 antibodies for use in immune and other diseases
EP2758433B1 (en) 2011-09-19 2017-10-18 Axon Neuroscience SE Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease
EP2794660A2 (en) 2011-12-23 2014-10-29 Phenoquest AG Antibodies for the treatment and diagnosis of affective and anxiety disorders
KR102234324B1 (en) 2012-12-21 2021-03-31 바이오젠 엠에이 인코포레이티드 Human anti-tau antibodies
EP3517545A1 (en) 2012-12-31 2019-07-31 Neurimmune Holding AG Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases
MX2017004213A (en) 2014-09-30 2017-07-19 Neurimmune Holding Ag Human-derived anti-dipeptide repeats (dprs) antibody.
MA44334A (en) 2015-10-29 2018-09-05 Novartis Ag ANTIBODY CONJUGATES INCLUDING A TOLL-TYPE RECEPTOR AGONIST
JP2018035137A (en) 2016-07-13 2018-03-08 マブイミューン ダイアグノスティックス エイジーＭａｂｉｍｍｕｎｅ Ｄｉａｇｎｏｓｔｉｃｓ Ａｇ Novel anti-fibroblast activated protein (FAP) binding agent and use thereof
JP2022520088A (en) 2019-02-13 2022-03-28 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド Anti-peripheral lymph node addressin antibody and its use
WO2022153212A1 (en) 2021-01-13 2022-07-21 Axon Neuroscience Se Antibodies neutralizing sars-cov-2

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747024A (en) * 1993-03-08 1998-05-05 Immunex Corporation Vaccine adjuvant comprising interleukin-15
US5763733A (en) * 1994-10-13 1998-06-09 Enzon, Inc. Antigen-binding fusion proteins
AU2273397A (en) * 1996-02-15 1997-09-02 Immunex Corporation Methods and compositions for modulating an immune response

Also Published As

Publication number Publication date
WO2000030680A1 (en) 2000-06-02

Similar Documents

Publication Publication Date Title
AU6625296A (en) Dna constructs
AU1631700A (en) Tumor antigen-specific antibody-gp39 chimeric protein constructs
GB9515941D0 (en) DNA constructs
AU2434199A (en) Protein
AUPP021197A0 (en) An improved water heater
AU1077200A (en) Novel chimeric polypeptide
AU1541699A (en) Human tumor necrosis factor-r2-like proteins
AU8500398A (en) Chimeric contraceptive vaccines
AU4974299A (en) Methods and constructs for protein expression
AU2452301A (en) Protein methylarginine-specific antibodies
AU1957299A (en) Presenilin protein interactions
AU7572198A (en) Tumor-associated antigen
GB9817909D0 (en) DNA constructs
AU3148099A (en) Chimeric insecticidal protein and gene coding therefore
AU5552700A (en) Chimeric proteins mediating targeted apoptosis
AU6983000A (en) Chimeric proteins
AU6891998A (en) Human tumor-associated membrane protein
AU2593199A (en) Human smn-like protein
AU6201298A (en) Ftcd antigen
AU4483597A (en) Novel tumor proteins
AU1763300A (en) Protein kinase targeting protein
AU6569998A (en) Obesity protein formulations
AU3056699A (en) Hair heater
AU6289999A (en) Follistatin-related protein zfsta2
AU6622798A (en) Nucleic acid constructs for durable transgene expression

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase